Wordt geladen...
Metronomic oral cyclosphosphamide as third-line systemic treatment or beyond in patients with inoperable locoregionally advanced recurrent or metastatic nasopharyngeal carcinoma
There is no standard third-line or further systemic treatment for patients with inoperable locoregionally advanced recurrent or metastatic nasopharyngeal carcinoma (NPC). Metronomic oral cyclophosphamide provides an acceptable and cheap option for these heavily pretreated patients who had limited ch...
Bewaard in:
Gepubliceerd in: | Medicine (Baltimore) |
---|---|
Hoofdauteurs: | , , , , , , , , , , , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
Wolters Kluwer Health
2017
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5403079/ https://ncbi.nlm.nih.gov/pubmed/28403082 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000006518 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|